Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
General Practitioners Research Institute
With
Boehringer Ingelheim
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary care patients with COPD aged 18 years and older with one or more (co)morbidities.
A clinical GP diagnosis of COPD (ICPC code R95 (emphysema/COPD).
Presence of one or more of the following (co)morbidities: Glaucoma (ICPC code F93\*), Kidney failure / renal insufficiency (ICPC code: U99.01), Tuberculosis (ICPC code: A70, R70), Diabetes (ICPC code: T90, A91.05), Pneumonia (ICPC code: R81, R81.01), Osteoporosis/osteopenia (ICPC code: L95, L95.02, L95.01), Prostate symptoms (ICPC code: Y06, U05.02), Atrium fibrillation (ICPC code: K78, K79, K80, K84.02, K04, K05), Bronchiectasis (ICPC code: R91, R91.02) and Asthma (ICPC code: R96, R96.02)
You may not be if
Have end-stage COPD or a life expectancy \< 6 months
If they underwent a systematic medication review aimed at reducing inappropriate prescribing. Systematic refers to a collaboration with a pharmacist and the adoption of Beers, STOPP and or START criteria.
Clareo Health | Managing Appropriate Prescribing in COPD
